Interleukin-6 Levels in Head and Neck Cancer Patients
Author Information
Author(s): O. Ga'ol, A.M. Gori, M. Attanasio, F. Martini, O. Fini-Storchil, R. Abbate
Primary Institution: University of Florence
Hypothesis
Does interleukin-6 serum concentration correlate with monocyte production in head and neck cancer patients?
Conclusion
Head and neck cancer patients have significantly higher levels of interleukin-6 in their serum and increased production by activated monocytes compared to healthy subjects.
Supporting Evidence
- IL-6 levels in the serum of head and neck cancer patients were significantly higher than in healthy controls.
- Monocytes from cancer patients produced more IL-6 when stimulated compared to those from healthy subjects.
- A significant correlation was found between IL-6 production by monocytes and serum IL-6 levels.
Takeaway
People with head and neck cancer have more of a substance called interleukin-6 in their blood, which helps their immune cells work harder.
Methodology
Monocytes were isolated from blood samples of cancer patients and healthy controls, and IL-6 levels were measured after stimulation with LPS.
Limitations
The study only included a small number of patients and did not account for all potential confounding factors.
Participant Demographics
19 male and 3 female patients with advanced head and neck cancer.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website